FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

Lisinopril/HCTZ 20mg/12.5mg Tablet

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot #: J0322819-091418, Exp: 09/30/2019
Where it was soldPA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-[redacted-phone] due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Distributed by / forRemedyRepack Inc.
NDC68180-0519-02
Show the full FDA record
Full product labelLisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202, NDC 68180-0519-02 (Original NDC of 500 count bottle); 70518-0382-03 (Repackaged NDC for blister cards).
Recalling firmRemedyRepack Inc.
DistributionPA
Quantity480 tablets
Recall initiated2019-08-05
Report date2020-03-25
Recall completed2023-06-02
Recall numberD-1030-2020
ClassificationClass II
FDA statusTerminated
Origin on fileIndiana PA United States

Related

Lisinopril recallsRecent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.